Atopic dermatitis (Q78805760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

review article

1 reference

title

Atopic dermatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Donald Y M Leung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Thomas Bieber

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

English

0 references

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

9352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

151-160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Changes in the reported prevalence of childhood eczema since the 1939-45 war

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

The excess of atopic eczema in East Germany is related to the intrinsic type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

The environmental predictors of allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

The role of lymphocytes in allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Diagnostic criteria for atopic dermatitis: where do we go from here?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Atopic dermatitis: new insights and opportunities for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

An obligate role for T-cell receptor alphabeta+ T cells but not T-cell receptor gammadelta+ T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Allergen sensitization through the skin induces systemic allergic responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Expression of IL-18 mRNA and secretion of IL-18 are reduced in monocytes from patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

The structure of normal skin and the morphology of atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

In vivo expression of IL-12 and IL-13 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

1 reference

7 January 2021

Antigen-presenting cells in allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Enhanced expression of eotaxin and CCR3 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Macrophage-derived chemokine production by activated human T cellsin vitro andin vivo: preferential association with the production of type 2 cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Identifying genes predisposing to atopic eczema☆☆☆★★★

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Atopic dermatitis is associated with a low-producer transforming growth factor β1 cytokine genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

A major susceptibility locus for atopic dermatitis maps to chromosome 3q21.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Food allergy. Part 1: immunopathogenesis and clinical disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

T-cell reactivity for a peanut-derived epitope in the skin of a young infant with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Murine model of atopic dermatitis associated with food hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Induction of atopic dermatitis by inhalation of house dust mite

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Autoallergy: a pathogenetic factor in atopic dermatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

The case for steroid--antibiotic combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Staphylococcal Toxins Augment Specific IgE Responses by Atopic Patients Exposed to Allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Topical corticosteroids and Staphylococcus aureus in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Systematic review of treatments for atopic eczema.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Lipid abnormalities in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Serum IgE reactivity to Malassezia furfur extract and recombinant M. furfur allergens in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Prevention of acute urticaria in young children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Recombinant interferon gamma therapy for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Traditional Chinese medicine for the treatment of dermatologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

Analysis of Chinese herbal creams prescribed for dermatological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912193-9

7 January 2021

10.1016/S0140-6736(03)12193-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12531593%20AND%20SRC:MED&resulttype=core&format=json